Regeneron scores victory against Eylea biosimilar as expedited trial tactic pays dividends

Regeneron scores victory against Eylea biosimilar as expedited trial tactic pays dividends

Meanwhile, the innovator has sued several more would-be competitors

Unlock unlimited access to all IAM content